Cooling Therapy and Thermoregulation
An innovative treatment for cardiac arrest, acute stroke, traumatic brain injury, acute myocardial infarction and sepsis, cooling therapy addresses the need for neuroprotection by cooling the brain.
NZMS has an agreement with PHARMAC to list ThermoWrap™ and the Allon™ system in Section H, Part III of the Pharmaceutical Schedule.
The concept of neuro-protection by hypothermia has taken a giant step into the future.The protective effects of hypothermia are due to:
- Reduction of cerebral metabolism, oxygen consumption, and glucose demand
- Slowing of the destructive neuroexcitatory process
- Decrease of free radical production
- Stabilisation of the blood-brain barrier
- Reduction of the inflammatory process
The CritiCool™ control unit is a microprocessor-controlled temperature management unit. Using feedback from the patient’s core and skin temperature sensors, the proprietary control algorithm responds by modifying water temperature such that patient target temperature will be achieved precisely. This achieves management of patient body temperature in a non-invasive, effective and precise manner. Criticool™ new touch screen is now available in New Zealand and is supplied by Belmont Medical Technologies.
Specially designed garments to obtain maximum thermal efficiency. CureWrap™ achieves high heat transfer by 3-dimensional surface coverage. CureWrap™ is constructed of flexible yet durable materials in view of well-being and comfort. CureWrap™ is available in various designs and sizes, ranging from infants to adults.
TARGETED TEMPERATURE MANAGEMENT
Building on the success of CritiCool®, CritiCool MINI offers a compact and portable design. CritiCool MINI functions as a thermal regulating system, precisely measuring the patient’s core temperature every 66 milliseconds and adjusting settings accordingly.
As with the original CritiCool control unit, the CritiCool MINI control unit is used with the flexible, single-patient CureWrap™